Portal de Periódicos da CAPES

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

2020; Elsevier BV; Volume: 135; Issue: 21 Linguagem: Inglês

10.1182/blood.2020006028

1528-0020

Joachim Yahalom, Bouthaina S. Dabaja, Umberto Ricardi, Andrea K. Ng, N. George Mikhaeel, Ivan R. Vogelius, Tim Illidge, Shunan Qi, Andrew Wirth, Lena Specht,

Effects of Radiation Exposure

Abstract The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.